{
    "Trade/Device Name(s)": [
        "ARCHITECT STAT High Sensitivity Troponin-I"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K191595",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "September 13, 2019",
    "Summary Letter Received Date": "June 17, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac troponin I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2 EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i2000SR System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT STAT High Sensitivity Troponin-I chemiluminescent microparticle immunoassay for quantitative determination of cardiac troponin I on the ARCHITECT i2000SR System.",
    "Indications for Use Summary": "Used as an aid in the diagnosis of myocardial infarction (MI) through quantitative determination of cardiac troponin I in human plasma (K2 EDTA) on the ARCHITECT i2000SR System.",
    "fda_folder": "Clinical Chemistry"
}